Glycomacropeptide-Based Protein Substitutes for Children with Phenylketonuria in Italy: A Nutritional Comparison
Advancements in food science technology have allowed the development of new products for the therapeutic management of inherited metabolic diseases such as phenylketonuria (PKU). Glycomacropeptide (GMP), a peptide derived from casein, is naturally low in phenylalanine (Phe) and, thus, adequate for p...
Main Authors: | Martina Tosi, Laura Fiori, Veronica Maria Tagi, Mirko Gambino, Chiara Montanari, Alessandra Bosetti, Gianvincenzo Zuccotti, Elvira Verduci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/16/7/956 |
Similar Items
-
Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
by: A. Pinto, et al.
Published: (2017-12-01) -
Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study
by: Chiara Montanari, et al.
Published: (2022-04-01) -
Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
by: Marta Delsoglio, et al.
Published: (2023-08-01) -
The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
by: Anne Daly, et al.
Published: (2020-09-01) -
Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
by: Maria João Pena, et al.
Published: (2021-02-01)